Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L W Lawrence

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Breast Cancer Research and Treatment|October 5, 2007
Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancerPaul A Foster, Surinder K Chander, Michael F C Parsons, et al.
Biochemistry|May 4, 2005
First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitorsMatthew D Lloyd, Nethaji Thiyagarajan, Yaik T Ho, et al.
Journal of Medicinal Chemistry|February 13, 2010
Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl templateL W Lawrence Woo, Toby Jackson, Aurélien Putey, et al.
Chemmedchem|July 16, 2010
Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activitiesPaul M Wood, L W Lawrence Woo, Jean-Robert Labrosse, et al.
Journal of Medicinal Chemistry|July 2, 2008
Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activityPaul M Wood, L W Lawrence Woo, Jean-Robert Labrosse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitorPaul A Foster, Surinder K Chander, Simon P Newman, et al.
Molecular Cancer Therapeutics|August 30, 2008
Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallographyL W Lawrence Woo, Delphine S Fischer, Christopher M Sharland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitorSusannah J Stanway, Atul Purohit, L W Lawrence Woo, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Breast Cancer Research and Treatment|October 5, 2007
Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancerPaul A Foster, Surinder K Chander, Michael F C Parsons, et al.
Biochemistry|May 4, 2005
First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitorsMatthew D Lloyd, Nethaji Thiyagarajan, Yaik T Ho, et al.
Journal of Medicinal Chemistry|February 13, 2010
Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl templateL W Lawrence Woo, Toby Jackson, Aurélien Putey, et al.
Chemmedchem|July 16, 2010
Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activitiesPaul M Wood, L W Lawrence Woo, Jean-Robert Labrosse, et al.
Journal of Medicinal Chemistry|July 2, 2008
Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activityPaul M Wood, L W Lawrence Woo, Jean-Robert Labrosse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitorPaul A Foster, Surinder K Chander, Simon P Newman, et al.
Molecular Cancer Therapeutics|August 30, 2008
Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallographyL W Lawrence Woo, Delphine S Fischer, Christopher M Sharland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitorSusannah J Stanway, Atul Purohit, L W Lawrence Woo, et al.
Pageof 4